CV Sciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
CV Sciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2017 to Q3 2024.
  • CV Sciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 182M shares, a 17.9% increase year-over-year.
  • CV Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 154M shares, a 11.5% increase from 2022.
  • CV Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 138M shares, a 28% increase from 2021.
  • CV Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 108M shares, a 7.91% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 182M +27.7M +17.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 172M +19.8M +13% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 163M +11M +7.21% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 154M +15.9M +11.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 155M +8.07M +5.51% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 153M +17.2M +12.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 152M +35.3M +30.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 138M +30.2M +28% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 147M +37.4M +34.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 135M +27.8M +25.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 117M +12.3M +11.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 108M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 109M +9.17M +9.17% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 108M +7.76M +7.77% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 105M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 100M +1.22M +1.23% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 99.9M -21.1M -17.4% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-07
Q4 2019 97.9M -16.6M -14.5% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-30
Q3 2019 98.7M -17.2M -14.8% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-06
Q2 2019 121M +8.46M +7.53% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 95.2M -468K -0.49% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
Q4 2018 114M +34M +42.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 116M +27.8M +31.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 112M +29.6M +35.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 95.6M +35.5M +59.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 80.4M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 88.1M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 82.9M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 60.1M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.